Partner meeting Aprile, 4-2012 Alberto Cremonesi.

Slides:

Advertisements

Similar presentations

ACTION Registry (Acute Coronary Treatment and Intervention Outcomes Network) Initial Report 1st Quarter 2007 Results Report prepared by: www. ncdr.com.

Advertisements

Optimal Timing of PCI in ACS Patrick Hildbrand. Trends and Prognosis in ACS Furman MI, JACC 2001, 37: Hospital 1 year.

Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.

Acute Coronary Syndromes Clinical Care Standard An introduction for clinicians and health services.

Primary PCI Treatment of choice for Acute MI.

GUSTO I GUSTO I Median Time (hrs) Between Symptom Onset and Treatment GUSTO III GUSTO III InTIME II InTIME II ASSENT.

What Do We Mean By Quality In PCI Institutional Requirements Dr Bernard Prendergast John Radcliffe Hospital, Oxford.

Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,

GP IIb/IIIa Inhibition in STEMI: Growing Clinical Trial Evidence.

Ten Points to Remember from the 2007 STEMI Guideline Update Based on the 2007 Focused Update of the 2004 Guidelines for the Management of Patients With.

ACS and Thrombosis in the Emergency Setting

Overview of Swedish Quality Registries Bertil Lindahl, Professor in Cardiology, Director of Uppsala Clinical Research center.

SWEDE HEART Prospective Registry based Randomized Clinical Trials (RRCT) – a new concept for clinical research Lessons from the TASTE trial Stefan James,

IOM Workshop on Standards for Clinical Guidelines Monday, January 11, 2010 Elizabeth Mort, MD, MPH Massachusetts General Hospital Partners HealthCare,

The Impact of Regional ST-Elevation Myocardial Infarction Systems of Care on the Use of Protocols and Quality Improvement Initiatives in Community Hospitals.

Role of Percutaneous coronary intervention (PCI) after thrombolytic therapy By Dr. Mohamed Mahros Assistant lecturer of cardiology Benha faculty of medicine.

Prospective, Randomized Evaluation of Immediate Versus Deferred Angioplasty in Patients with High Risk Acute Coronary Syndromes RK Riezebos 1, E Ronner.

Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.

Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.

Lysis and Beyond: ESC Guidelines and Reality J N Townend Queen Elizabeth Hospital Birmingham.

Update of 2013 ACCF/AHA Guidelines for STEMI Junbo Ge MD,FACC,FESC,FSCAI Zhongshan Hospital, Fudan University.

Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.

The Health Roundtable Saving heart muscle by reducing delays to getting patients to the overnight regional catheter lab Presenter: Debby Hailstone Middlemore.

Ravi Doobay and Dr. Eric Harrison We care about the health of our firefighters Tampa Fire Rescue: Saving our Firefighters from Heart Disease.

Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.

Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?

Managing AMI – much work still to do? MONDAY, 28 th FEBRUARY – SESSION 3 Patrick Goldstein EXPERTS WORKSHOP ON EARLY TREATMENT STRATEGIES FOR ACUTE MYOCARDIAL.

Door to Balloon Time: Does it Matter? Tale of Two Studies.

Dallas 2015 TFQO: Karen Woolfrey #COI 261 EVREV 1: Karen Woolfrey # COI 261 EVREV 2: Daniel Pichel #COI 513 Taskforce: ACS ACS 872: Pre-hospital Diversion.

Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2007 Focused Update of the ACC/AHA 2004 Guidelines.

High-risk ST elevation MI patients (>4 mm elevation), Sx < 12 hrs 5 PCI centers (n=443) and 22 referring hospitals (n=1,129), transfer in < 3 hrs High-risk.

Cardiac causes of cardiac arrest

A Clinical profile of patients enrolled in the Pakistan ACS registry

The American College of Cardiology Presented by Dr. Adnan Kastrati

Floriane Zeyons, MD University Hospital of Strasbourg, France

The Association between Prehospital Time Intervals and ST-Elevation Myocardial Infarction System Performance.

The European Society of Cardiology Presented by Dr. Bo Lagerqvist

Copyright © 2005 American Medical Association. All rights reserved.

Eva Kline-Rogers RN, NP, AACC University of Michigan

How to Promote Women Awareness to Heart Disease and the Role for Women

The DANAMI-2 Trial Danish Trial in Acute Myocardial Infarction-2

Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study Xin Zheng,

ATLANTIC Trial design: Participants with STEMI being transported for primary PCI were randomized in the ambulance to ticagrelor 180 mg (n = 909) vs. placebo.

STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES

Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial

European Society of Cardiology 2003

The Management of ACS “Updated Perspectives and Goals” Rafid F. Al-Aqeedi FIBMS ( Med ), MRCP (London), DM ( Int.Card.), FACC, FESC Consultant Interventional.

Fewer PCIs After Public Reporting Changes in NY

Figure 2 Ischaemic and bleeding outcomes in the major clinical trials

Invasive versus conservative treatment in unstable coronary syndromes

Figure 1 PCI strategies in patients with STEMI and multivessel disease

Nat. Rev. Cardiol. doi: /nrcardio

Published in the European Heart Journal

TRIAL HIGHLIGHT FROM ESC 2016: ACUTE CORONARY SYNDROMES

The European Society of Cardiology Presented by RJ De Winter

American College of Cardiology Presented by Dr. Michel R. Le May

Figure 4 Observational studies on multiple treatment strategies

Global Registry of Acute Coronary Events: GRACE

Volume 383, Issue 9925, Pages (April 2014)

Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.

China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.

European Heart Journal Advance Access

Management of AMI in patients presenting with STEMI

The Case for Routine CYP2C19 ( Plavix® ) Genetic Testing

ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.

Lee A. Fleisher et al. JACC 2014;64:e77-e137

Any, acute and subacute stent thrombosis with bivalirudin versus unfractionated heparin (UFH) in predominantly ST segment elevation myocardial infarction.

MRRs and EMRRs for women with ACS

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

16-year follow-up of the DANish Acute Myocardial Infarction 2 (DANAMI-2) trial PG Thranea, SD Kristensena, KKW Olesena, LS Mortensenb, HE Bøtkera, L.

Presentation transcript:

Partner meeting Aprile, Alberto Cremonesi

RecommendationsClassLOE 1. PPCI for STEMI (within 2 hours) 2. Rescue PCI for failed fibrinolysis (within 12 hours) 3.PCI for STEMI with shock and contraindications to fibrinolythic therapy irrespective of time delay 4. Angiography and PCI after successful fibrinolysis (within 24 hours) 5. Urgent PCI for hemodynamically unstable NSTE-ACS (within 2 hours) 6. Early PCI for high-risk NSTE-ACS (within 72 hours) I IIa I IIa I AABACAAABACA ESC Guidelines: PCI for acute CAD

≥600 p-PCI / million / year p-PCI / million / year p-PCI / million / year <200 p-PCI / million / year Data not known Annual Incidence of Primary PCIs

Reperfusion Therapies Differ in Countries P.Widimsky et al. November 19, Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur. Heart.J.doi: /eurheartj/ehp492

Only 55% of all PCI centers offer non-stop 24/7 p-PCI service  55%

Only 51% STEMI patients arrive to the first hospital by EMS

Summary: The mismatch between scientific evidence and daily practice

Stent for Life Initiative Objectives Define regions/countries with an unmet medical need in the optimal treatment of ACS. Implement an action program to increase patient access to primary PCI where indicated: – To increase the use of primary PCI to more than 70% among all ST segment elevation myocardial infarction patients, – To achieve primary PCI rates of more than 600 per one million inhabitants per year, – To offer 24/7 service for primary PCI procedures at all invasive facilities to cover the country STEMI population need.

STENT for LIFE

Stent for Life Initiative ITALIA Kick-off Meeting, Rome - April 8 th 2011

Iniziative chiave: Stent For Life Italia

PCI primarie/ abitanti N %

Iniziative chiave: Stent For Life Italia

Active involvement of institutional stakeholders in health economics Reliable clinical data Cost-efficacy studies Risk sharing agreement Price transparency Health Technology Assessment